Wasatch Advisors LP Buys New Holdings in Tarsus Pharmaceuticals, Inc. $TARS
Market Beat·
- Wasatch Advisors LP purchased a new position of 368,568 shares in Tarsus Pharmaceuticals, Inc. valued at approximately $23,198,000 during the 2nd quarter.
- Institutional investors and hedge funds currently own 90.01% of the company's stock following recent stake adjustments by various major investment firms.
- Tarsus Pharmaceuticals reported second-quarter revenue of $173.91 million and earnings per share of ($0.43), alongside recent insider stock sales by company executives.